Quantum Cyber N.V. Profit Loss Before Tax
Quantum Cyber N.V. (QUCY) reported Profit Loss Before Tax of -$8.34 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2025-09-26
- Quantum Cyber N.V. profit loss before tax for the quarter ending 2023-12-31 was -$5.18M.
- Quantum Cyber N.V. profit loss before tax for the quarter ending 2023-09-30 was -$6.30M.
- Quantum Cyber N.V. profit loss before tax for the quarter ending 2023-06-30 was -$8.25M.
- Quantum Cyber N.V. profit loss before tax for the quarter ending 2023-03-31 was -$6.56M.
| Period end | Profit Loss Before Tax 3 month | Profit Loss Before Tax 6 month | Profit Loss Before Tax 9 month | Profit Loss Before Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$8.34M 6-K · filed 2025-09-26 | |||
| 2024-12-31 | -$21.65M 20-F · filed 2025-03-31 | |||
| 2024-06-30 | -$11.02M 6-K · filed 2025-09-26 | |||
| 2023-12-31 | -$5.18M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$11.48M derived: sum of 2 quarters · filed 2025-03-31 | -$19.73M derived: sum of 3 quarters · filed 2025-03-31 | -$26.30M 20-F · filed 2025-03-31 |
| 2023-09-30 | -$6.30M 6-K · filed 2023-11-16 | -$14.55M derived: sum of 2 quarters · filed 2023-11-16 | -$21.11M 6-K · filed 2023-11-16 | -$29.30M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$8.25M 6-K · filed 2023-08-15 | -$14.81M 6-K · filed 2024-10-18 | -$23.00M derived: sum of 3 quarters · filed 2025-03-31 | -$28.60M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$6.56M 6-K · filed 2023-05-16 | -$14.75M derived: sum of 2 quarters · filed 2025-03-31 | -$20.35M derived: sum of 3 quarters · filed 2025-03-31 | -$27.28M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$8.19M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$13.78M derived: sum of 2 quarters · filed 2025-03-31 | -$20.72M derived: sum of 3 quarters · filed 2025-03-31 | -$26.39M 20-F · filed 2025-03-31 |
| 2022-09-30 | -$5.60M 6-K · filed 2023-11-16 | -$12.53M derived: sum of 2 quarters · filed 2023-11-16 | -$18.20M 6-K · filed 2023-11-16 | |
| 2022-06-30 | -$6.94M 6-K · filed 2023-08-15 | -$12.60M 6-K · filed 2023-08-15 | ||
| 2022-03-31 | -$5.66M 6-K · filed 2023-05-16 | |||
| 2021-12-31 | -$11.69M 20-F · filed 2024-04-09 | |||
| 2021-06-30 | -$261.72K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | -$586.89K 20-F · filed 2023-04-07 | |||
| 2019-12-31 | -$957.05K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |